Position in PTGX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$10,441,364
+$403,595 QoQ
Shares Held
85,180
-10.6% QoQ
Ownership
0.132%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#74
of 343 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRUDENTIAL FINANCIAL INC holds $556,047,667 across 189 Biotechnology names. PTGX ranks #12 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
130,659 | $81,471,112 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
133,294 | $66,211,127 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
392,811 | $22,476,644 | |
| 4 | INCY |
Incyte Corp
|
191,312 | $21,687,128 | |
| 5 | CYTK |
Cytokinetics Inc
|
214,535 | $18,276,236 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
|
54,623 | $17,265,784 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
185,820 | $15,157,337 | |
| 8 | MRVI |
Maravai Lifesciences Holdings, Inc.
|
2,152,154 | $13,429,440 |
All Filings in PTGX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,441,364 | 85,180 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $10,037,769 | 95,235 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $9,638,842 | 110,360 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $8,396,951 | 126,403 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $4,278,340 | 77,408 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $2,822,192 | 58,358 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,315,922 | 59,998 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $2,735,910 | 60,798 | Shares | Defined | 2024-11-14 | |
| 2023-03-31 | $1,547,739 | 67,293 | Shares | Defined | 2023-05-12 | |
| 2022-03-31 | $544,474 | 22,993 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,029,591 | 30,105 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $536,827 | 30,295 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,339,443 | 29,845 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $870,628 | 33,615 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $883,512 | 43,825 | Shares | Defined | 2021-08-16 | |
| 2020-09-30 | $1,075,543 | 55,015 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $1,188,606 | 67,305 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $510,720 | 72,340 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||